Bilski's Broad Sweep: Federal Circuit Says Vaccination Schedule Analysis Is Patentable
This article was originally published in The Pink Sheet Daily
Executive Summary
In Classen v. Biogen Idec the court rules that patents on a method of determining the administration schedule of vaccines are patent-eligible; the case applies the Supreme Court's Bilski decision on process patents to the biotech field.